-
Health care giant Johnson & Johnson says sales rebounded but its profit dropped 23 percent in the first quarter, due to higher expenses, costs of recalls and litigation and a tax gain that boosted results a year ago. Adjusted earnings topped expectations. J&J also raised its full-year earnings outlook.

See the rest here:
BloggingStocksLoading...




0 Comment - Post your comment